Evidence map›Paper›PMID 36368736›Full record

ArticleBMJ case reports2022

Sino-orbital metastasis as the initial presentation of advanced breast cancer.

Mohamad Kamil Muhammad-Ikmal, Nurul Ain Masnon, Firdaus Hayati, Wan-Hazabbah Wan HItam

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mohamad Kamil Muhammad-IkmalDepartment of Ophthalmology, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia dr.ikmalkamil@ums.edu.my.ORCID http://orcid.org/0000-0002-2003-9645
Nurul Ain MasnonDepartment of Ophthalmology and Visual Sciences, Universiti Sains Malaysia - Health Campus, Kubang Kerian, Kelantan, Malaysia.
Firdaus HayatiDepartment of Surgery, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.
Wan-Hazabbah Wan HItamDepartment of Ophthalmology and Visual Sciences, Universiti Sains Malaysia - Health Campus, Kubang Kerian, Kelantan, Malaysia.ORCID http://orcid.org/0000-0002-3737-1820
Hospital Universiti Sains Malaysia · MYUniversiti of Malaysia Sabah · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A woman in her 70s presented with reduced vision in her left eye, progressive narrowing of right eye opening for 6 months and anosmia. On examination, she had right enophthalmos and pseudoptosis with inferior globe dystopia. Her visual acuity was 6/9 and nil light perception in the right and left eyes, respectively. Extraocular muscle examination showed limited right up gaze. Funduscopy showed a normal right optic disc and left optic disc atrophy. Systemic examination revealed left breast ulceration with skin tethering. CT revealed an infiltrative mass invading the ethmoidal sinuses, frontal sinuses and both orbits. A histological diagnosis of infiltrative ductal breast carcinoma was made after nasal endoscopic and left breast biopsy. She underwent palliative chemoradiotherapy and survived with good disease control after 1 year. Metastatic carcinoma is a differential diagnosis of a sino-orbital mass, and comprehensive clinical assessment is indicated for all patients presenting with non-acute eye injury.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastEnophthalmosOrbital NeoplasmsFemaleHumansVisual AcuityBreast cancerChemotherapyHead and neck cancerRadiotherapyVisual pathway

Identifiers

PMID36368736
PMCPMC9660501
OpenAlexW4308797867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.